Zacks Investment Research
11 Aug 2026, 15:46 UTC · 3h ago
Implied Volatility Surging for BioCryst Pharmaceuticals Stock Options
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
11 Aug 2026, 15:46 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
BioCryst Pharmaceuticals (BCRX) Sep 18, 2026 $2 Put options are exhibiting some of the highest implied volatility among all equity options. — High implied volatility indicates the market expects a significant price swing, though the direction is not specified.
+0.30Analysts have revised the Zacks Consensus Estimate for BioCryst Pharmaceuticals' current quarter upward from 3 cents to 7 cents per share. — Positive earnings revisions generally signal improved fundamental expectations and support a bullish outlook.
+0.20BioCryst Pharmaceuticals currently holds a Zacks Rank #2 (Buy) rating. — A 'Buy' rating is a positive signal, though a Rank #2 is slightly less impactful than a Rank #1 'Strong Buy'.
+0.10Continue reading
6 related stories
Top 2 movers · tap to explore
The Medical – Drugs industry, in which BCRX operates, ranks in the bottom 40% of the Zacks Industry Rank. — Poor industry relative ranking suggests a challenging macroeconomic or sector-specific environment for the company.
-0.10Which stocks this story touches
The company has a Zacks Rank #2 (Buy) and analysts have increased earnings estimates for the current quarter.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
2h ago
